Omnicell Inc (OMCL)

NASDAQ · Health Care

36.65
-0.23 (-0.62%)
Updated Nov 2, 3:05 AM ET
AI Rating
Hold
Overall Score
64
Trend
43
Momentum
90
Risk
63

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 20, 2025 260 sessions Oct 30, 2026

AI Analysis

Omnicell Inc is trading at $36.65, down 0.62% on the session. The 50 day average sits at $34.60 and the 200 day at $39.03, which puts the stock in a downtrend. RSI is at 55.5, which reads as strong, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $35.07 with resistance near $37.32, so that band frames the current range. Average daily movement is roughly $1.41, or about 3.9% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 43, momentum of 90 and a risk score of 63.

Technical indicators

RSI (14)
55.5
strong
MACD
0.587
bullish crossover
SMA 20
36.14
SMA 50
34.60
SMA 200
39.03
downtrend
ATR (14)
1.41
avg daily range
Support
35.07
Resistance
37.32
Volume vs 20d
1.54x
volume spike
Volatility
31.1%
annualised
1 month
+9.60%
3 months
-2.66%

About Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.